Roboshan, I don't think we are too far away from each other as to what we see as a "logical" final result, given the state of the pharmaceutical wholesaling market...Where we differ, however, is the concept of who is the suitor, and who is the prey....To me, IMHO it would make far more sense for Sigma to re-establish some operational continuity, and then in time launch on API, not vise-verca....I see Sigma as having a more credible suite of pharmacy offerings moving forward, rather than the "one trick pony" which is API.
Mate, I just don't rate API's capacity to move forward...Ask your buddies dealing with all three, & see who has the best stock inventories at the moment...
Ann: API: Market update on API-Sigma merger proposal, page-22
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.39 |
Change
-0.030(1.24%) |
Mkt cap ! $3.900B | |||
| Open | High | Low | Value | Volume |
| $2.43 | $2.44 | $2.33 | $20.73M | 8.730M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1857 | $2.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.40 | 13500 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SIG (ASX) Chart |